一个患有脑炎的婴儿.

Same author

Across time and space: phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii in a network of general and convalescent hospitals.

The Journal of hospital infection·2025

Same author

Molecular stratification of gliomas using next-generation sequencing: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2025

Same author

Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas.

bioRxiv : the preprint server for biology·2025

Same author

Skin microbial signatures for eczema: a birth cohort study (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2024

Same author

Limb presentations of invasive Group A Streptococci infection in children.

JPRAS open·2024

Same author

Genome-wide DNA methylation profiling for central nervous system embryonal tumours in children: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2024

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

一个患有脑炎的婴儿.

相关概念视频

Across time and space: phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii in a network of general and convalescent hospitals.

Molecular stratification of gliomas using next-generation sequencing: abridged secondary publication.

Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas.

Skin microbial signatures for eczema: a birth cohort study (abridged secondary publication).

Limb presentations of invasive Group A Streptococci infection in children.

Genome-wide DNA methylation profiling for central nervous system embryonal tumours in children: abridged secondary publication.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

一个患有脑炎的婴儿.

相关概念视频

相关文章

Across time and space: phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii in a network of general and convalescent hospitals.

Molecular stratification of gliomas using next-generation sequencing: abridged secondary publication.

Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas.

Skin microbial signatures for eczema: a birth cohort study (abridged secondary publication).

Limb presentations of invasive Group A Streptococci infection in children.

Genome-wide DNA methylation profiling for central nervous system embryonal tumours in children: abridged secondary publication.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.